Kevin King

Kevin King is an accomplished executive with extensive experience in the biotechnology sector. Currently serving as the Senior Director of CGT Strategy and Growth and Senior Director of Immune Cell Operations at BioIVT since October 2019, Kevin played a pivotal role in the recent acquisition of Physicians Plasma Alliance (PPA) and PPA Research Group. Prior to this, Kevin was the President and CEO of Physicians Plasma Alliance and the CEO/Owner of PPA Research Group from July 2009 to October 2019, demonstrating a strong leadership presence and a commitment to advancing the field of plasma research and operations.